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might exploit a similar strategy based on a very
efficient capture mechanism at specialized NMJ
sites rich in nidogens, which may function to
concentrate TeNT as well as physiological lig-
ands, such as neurotrophic factors, to facilitate
their uptake and sorting to axonal transport or-
ganelles. At these sites, TeNT in complex with
nidogens may interact with surface receptors
known to bind nidogens, such as the protein phos-
phatase LAR (29, 30). This specialized capture
mechanism is likely to be indispensable to the
host cell, and this enables TeNT to be lethal at
extremely low concentrations. Our study sug-
gests that nidogens are prime therapeutic targets
for suppressing the uptake of TeNT at the NMJ
and its access to the CNS, preventing its lethal
effects.
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T CELL SIGNALING
Antigen affinity, costimulation, and
cytokine inputs sum linearly to
amplify T cell expansion
Julia M. Marchingo,1,2 Andrey Kan,1,2 Robyn M. Sutherland,1,2 Ken R. Duffy,3
Cameron J. Wellard,1,2 Gabrielle T. Belz,1,2 Andrew M. Lew,1,2 Mark R. Dowling,1,2,4
Susanne Heinzel,1,2* Philip D. Hodgkin1,2*†
Tcell responses are initiated by antigen and promoted by a range of costimulatory signals.
Understanding how Tcells integrate alternative signal combinations and make decisions
affecting immune response strength or tolerance poses a considerable theoretical challenge.
Here, we report that Tcell receptor (TCR) and costimulatory signals imprint an early,
cell-intrinsic, division fate, whereby cells effectively count through generations before returning
automatically to a quiescent state.This autonomous program can be extended by cytokines.
Signals from the TCR, costimulatory receptors, and cytokines add together using a linear
division calculus, allowing the strength of a Tcell response to be predicted from the sum of the
underlying signal components.These data resolve a long-standing costimulation paradox and
provide a quantitative paradigm for therapeutically manipulating immune response strength.
U
pon infection, pathogen-specific CD8+T cells
undergo a characteristic kinetic sequence:
rapid proliferation and expansion followed
by population contraction due to cell death
(1). While short-term stimulation is suf-
ficient to trigger CD8+ T cell proliferation (2, 3),
further exposure to stimulatory signals is required
for an effective response (2, 4, 5). Although mul-
tiple attempts have been made to create a theory
relating the integration of stimulatory signals to
T cell response strength, all have been qualitative
(6) and thus have lacked the power to predict the
quantitative effect of altering stimulatory combi-
nations and strength. The current qualitative par-
adigm describes T cell activation and response
magnitude as the outcome of three requisite sig-
nals: signal 1, T cell receptor (TCR) (1); signal 2,
membrane-bound antigen-presenting cell (APC)–
delivered costimuli (4); and signal 3, cytokines
from inflammatory, homeostatic, or autocrine
sources (5). The importance of these signals for
T cell expansion is highly context-dependent, as
classic in vitro studies have identified many “crit-
ical” signal 2 and 3 molecules (5, 7–9); however,
gene deletion typically yields only moderate de-
fects in the in vivo CD8+ T cell response (10–13),
implying considerable redundancy.
Recent studies in B cells report an automated
return to quiescence after a series of division
rounds (14–16). The number of mitotic cycles B
cells undergo varies and is influenced by the
strength of stimulation. We hypothesized that
T cells might be programmed in a similar man-
ner with the final number of divisions (N) (Fig. 1A,
left panel) a function of the sum of inputs from
signals 1, 2, and 3 (illustrated in Fig. 1A). If cor-
rect, it may be possible to determine the calculus
of addition to serve as the basis for a quantitative
framework for T cell costimulation.
To test this hypothesis, we first measured the
onset of quiescence in CD8+ T cells using TCR-
transgenic OT-I mice [which recognize chicken
ovalbumin SIINFEKL (N4) peptide bound to
H2Kb] crossed with FucciRG mice in which cells
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fluoresce red (FucciR) during G0/G1 and green
(FucciG) for the duration of the S/G2/M cell
cycle phases (17). Quiescent (FucciR+G–), recently
divided (FucciR–G–), and actively dividing (FucciG+)
cells can be distinguished, because cells that have
reverted to a quiescent state (G0) accumulate high-
er levels of FucciR (17, 18). We define the number
of generations of division before returning to
quiescence as the cell’s division destiny (DD)
(14–16, 19). OT-I/FucciRG CD8+ T cells were
transferred into mice infected with recombinant
HKx31 influenza virus expressing N4 (HKx31-N4)
(20). During early expansion,most OT-I/FucciRG
CD8+ T cells were proliferative, with <10% revert-
ing to a quiescent state by day 3 of the response.
This proportion of quiescent cells increased stead-
ily, reaching ~75%of all OT-I/FucciRGCD8+ T cells
by the onset of contraction at day 7 (Fig. 1, B andC).
To estimate the number of divisions T cells under-
went before dropping out of cycle, the Cytonmodel
(15, 21) was fitted to total and quiescent cell num-
bers (Fig. 1D and table S1). Results were consistent
with a T cell DD range spanning ~10 genera-
tions (Fig. 1E). If DD is carried through each cell
lineage (16), this result predicts up to 1000-fold
differences in T cell family size consistent with
recent single-cell tracking studies (22, 23).
To further explore the regulation of division
progression, we developed aminimal in vitro stim-
ulation system using CellTrace Violet (CTV)–labeled
OT-I/FucciRG CD8+ T cells. The contribution of
signals 2 and 3 was reduced by using peptide self-
presentation by purified CD8+ T cells (24). The
strong effect of autocrine interleukin-2 (IL-2) was
controlled by adding blocking antibody (clone
S4B6) and using human IL-2 (hIL-2), resistant to
S4B6, when required (25). Superficially the in vitro
pattern of early proliferation with a gradual on-
set of quiescence recapitulated the in vivo re-
sponse (Fig. 1, C and F), with the major differences
being the DD and subsequent time to die (Fig. 1,
D, E, and G, and table S1).
We speculated that the three known sources of
regulation—TCR affinity, costimuli, and cytokines—
might combine to convert the low DD observed
in vitro into the extensive outcome possible in vivo
(Fig. 1E).
To improve estimation of mean DD (mDD)
in our in vitro CTV division tracking assay, we
used OT-I CD8+ T cells deficient in the pro-
apoptotic molecule Bim (OT-I/Bcl2l11−/−) for all
experiments. These cells reported the samemDD
as OT-I/Bcl2l11+/+ CD8+ T cells (Fig. 2A; fig. S1, A
to C; and table S2), but the enhanced survival
upon reverting to quiescence facilitated DDmea-
surement at later times, consistent with previous
studies in B cells (15, 16).
Fig. S2, A to F, shows the effect of a range of
T cell stimuli on mDD. TCR affinity, several ago-
nists representative of cell-contact–mediated co-
stimulation, and some, but not all, cytokines tested
were able to regulate DD in a dose-dependent
manner. To determine when DD was most sus-
ceptible to regulation, cells from cultures where
stimulation was removed immediately before the
first division (24) were compared to cells with
constant costimulation. Agonist antibodies to
CD28 and CD27 principally acted before the
first division. In contrast, ongoing exposure to
IL-2, IL-4, and IL-12 was required for maximal
proliferation (Fig. 2B). Higher levels of IL-2 or
IL-4 caused T cells to divide beyond CTV res-
olution (fig. S3) and the culture capacity. There-
fore, to investigate the potential of IL-2 and IL-4
to extend DD when cytokine levels were main-
tained, OT-I/Bcl2l11−/− CD8+ T cells were sub-
cultured every 48 hours in hIL-2 (Fig. 2C) or IL-4
(fig. S4A), and total cell numbers were calculated
using splitting ratios. Cyton fitting revealed that
hIL-2 and IL-4 can increase the mDD by up to
~11 and 7 divisions, respectively (Fig. 2, C to E;
fig. S4, A and B; and tables S3 and S4). Titration
of hIL-2 showed the effect on mDD to be dose
dependent (Fig. 2D) and that this increase in
mDD was associated with an increase in var-
iance (Fig. 2E and fig. S4C). Together these re-
sults demonstrated that DD can be intrinsically
programmed by early signals, but also has the
flexibility to be “reprogrammed” or extended by
extrinsic stimuli as the T cells divide.
We then determined how T cells integrated
multiple contributors to DD. In Fig. 3, A and B,
we show the increase in mDD imprinted before
the first division for low concentrations of CD28
and CD27 agonist antibodies, and IL-12 protein.
The combination of antibodies to CD28 and CD27
programmed an mDD that was equivalent to the
sum of each individual effect, with IL-12 giving a
slightly greater than additive increase in mDD
1124 28 NOVEMBER 2014 • VOL 346 ISSUE 6213 sciencemag.org SCIENCE
Fig. 1. CD8+ T cells undergo a program of prolifer-
ation and quiescence in vivo and in vitro. (A) Quan-
titative T cell expansion hypothesis. By this model,
the number of mitotic cycles a Tcell undergoes after
activation (N) varies and is determined by a sum of
the individual inputs it receives. In the example shown,
signal 1, 2, and 3 stimuli each individually elicit a small
increase in mean population division number. The cu-
mulative effect of these contributions, when summed
linearly, would lead to geometric increases in total cell
number at the peak response. Analysis of OT-I/FucciRG
CD8+ T cells [(B) to (E)] transferred to HKx31-N4–
infected recipients on day 2 after infection or [(E) to
(G)] in vitro stimulatedwith N4 in the presence ofmIL-2
blocking antibody (S4B6). (B) Number and (C) per-
centage of OT-I/FucciRG CD8+ Tcells expressing FucciR
and FucciG reporter proteins pooled from mediastinal
lymph node, spleen, and lungs at the indicated time
points after transfer. (D) Fitted total (black) andquiescent
(red, FucciR+G– + small FucciR–G– cells) cell numbers
using the Cyton model (19). (E) The estimated DD
distribution from Cyton fitting to in vivo (D) and in vitro
(G) stimulated cells. (F) Percentage of FucciR and FucciG
expression. (G) Fitted total (black) and quiescent (red,
FucciR+G– + small FucciR–G– cells) cell numbers (19).
[(B) to (E)] n = 5 to 10 mice per time point, pooled
from two independent experiments; mean T SEM. [(E)
to (G)] Representative of three independent experi-
ments; mean T SEM from triplicate culture wells.
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(Fig. 3, C and D). Importantly, no single “second
signal” appeared obligatory, but rather multiple
small arithmetic effects on DD culminated in
large geometric differences in the cell numbers
produced (Fig. 1A, center and right panels). Thus,
an increase of ~2.2 divisions in mDD (Fig. 3D)
with the accompanying ~0.5 division increase in
standard deviation (fig. S5, A to D, and table S5)
summed from three weak costimuli resulted in
a net ~8-fold increase in the peak cell number
(Fig. 3, E and F), with the additional difference
in response magnitude attributable to small
variations in the starting cell number (fig. S5E
and table S5). Early programming was cell
intrinsic because cells imprintedwith anmDD of
~1 or ~3.4 generations gave the same outcome
irrespective of whether they were subsequently
cultured separately or together (fig. S6, A and B).
The approximately additive effect of stimuli on
DDalso applied for a range of combinationswhen
stimuli were retained in culture during subse-
quent division rounds (fig. S7, A to D).
Taken together, this series of experiments re-
veals two stages of regulation of T cell DD. In the
first stage, signal 1 and a series of signal 2 and 3
stimuli of different strengths and combinations
can additively “program” a heritable number of
division rounds before the first cell division. In
the second stage, exposure to external signals,
mainly cytokines, can be processed and added to
the DD. These features are consistent with a mo-
lecular mechanism whereby each stimulatory sig-
nal contributes a quantum of mitosis-promoting
SCIENCE sciencemag.org 28 NOVEMBER 2014 • VOL 346 ISSUE 6213 1125
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Fig. 3. Summation of DD from multiple costimuli
geometrically amplifies the T cell response. Per-
centage cohort number (Fig. 2A) (19) versus mean
division number for N4-stimulated, CTV-labeled OT-
I/Bcl2l11−/− CD8+ Tcells cultured with (A) antibodies
to CD27 (immobilized, 5 mg/mL) and CD28 (2 mg/mL)
or (B) IL-12 protein (1 ng/mL) alone, (C) antibodies to
CD27 and CD28 together, or (D) a combination of all
three costimuli for 26 hours, washed and recultured
without further stimulation. Relationship between
cell number and either (E) mean division number or
(F) time for data in [(A) to (D)]. Arrows represent the
effect of individual stimuli on mDD. All cultures con-
tained S4B6 at 25 mg/mL. Graphs are representative
of three independent experiments; mean T SEM of
triplicate culture wells.
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Fig. 2. Costimuli and cytokines program changes to
DD. (A) CTV-labeled OT-I/Bcl2l11+/+ or OT-I/Bcl2l11−/−
CD8+ Tcells were stimulated with N4; total cell num-
bers (left), mean division number (middle), and an es-
timation of the percentage of the starting cells whose
progeny are contributing to the response at that time
point, calculated by removing the effect of cell expan-
sion at each time point [percent cohort number, right;
as described in (19)]were determined.MeanDD (mDD)
on each graph is indicated by dotted lines. (B) Mean
division number of CTV-labeledOT-I/Bcl2l11−/−CD8+ T
cells cultured in thepresence (+, solid lines) or absence
(–, dotted lines) of antibodies to CD28 (2 mg/mL) and
CD27 (immobilized, 5 mg/mL) (blue), IL-12 (1 ng/mL),
human IL-2 (hIL-2, 31.6 U/mL), or IL-4 (1000 U/mL)
(red) for 26 hours, washed and further cultured with
(dark) orwithout (light) costimulation. (C) CTV-labeled
OT-I/Bcl2l11−/− CD8+ Tcells stimulated with N4 in the
presence of hIL-2 at the indicated concentrations were
subcultured into fresh hIL-2 every ~48 hours and the
cell number was fitted using the Cyton model (dotted
lines) (19). (D and E) Dose-response curve ofmDD (D)
and DD distributions (E) from Cyton fitting in (C). All
cultures contained 25 mg/mLS4B6. Representative of
at least two independent experiments; mean T SEM
from triplicate culture wells.
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protein or complex that is diluted by division until
a submitotic concentration is reached and division
ceases (26).
The two-stage DD programmingmodel makes
two key predictions for the role of extrinsic fac-
tors, such as IL-2, that could be tested during in
vivo CD8+ T cell responses: (i) the major phys-
iological role of autocrine IL-2 is in maintaining
division, and therefore it will be more important
away from the initial site of CD8+ T cell priming;
and (ii) the effect of IL-2 on DD will sum with
other stimuli, allowing the prediction of CD8+ T
cell expansion kinetics when IL-2 and other
stimuli are combined.
We tested the first prediction by comparing the
expansionof IL-2 receptora–deficientOT-I CD8+T
cells (OT-I/Il2ra−/−)withOT-I/Il2ra+/+CD8+T cells
in two different in vivo systems, namely an anti-
influenza response and islet graft rejection mod-
el. Similar numbers of OT-I/Il2ra+/+ and OT-I/
Il2ra−/− CD8+ T cells were detected at the site of
priming [mediastinal lymph node (mLN)] during
the expansion phase when cotransferred into
HKx31-N4 infected mice (Fig. 4A). In contrast, a
bias toward expansion of OT-I/Il2ra+/+ CD8+ T
cells was observed in the spleen and lungs, con-
sistent with a role for IL-2 in the maintenance of
cell expansion (Fig. 4A). OT-I/Il2ra+/+ CD8+ T cells
also outcompeted OT-I/Il2ra−/− CD8+ T cells at the
effector site during an anti-islet graft response
(Fig. 4B). The proportion of bromodeoxyuridine-
positive (BrdU+) OT-I/Il2ra+/+ CD8+ T cells after
a 1-hour in vivo BrdU pulse was ~2.5 times as
high as for OT-I/Il2ra−/− CD8+ T cells in the graft
(Fig. 4C), confirming that this bias was attribut-
able to proliferation in the effector site and not
due to migration alone (27).
To investigate the additive nature of T cell
stimuli in vivo,OT-I/Il2ra+/+ andOT-I/Il2ra−/−CD8+
T cells were cotransferred intomice infected with
either high-affinity (HKx31-N4) or low-affinity
(HKx31-Q4) influenza virus (20). The Cytonmodel
was fitted to T cell numbers to estimate the in-
crease in DD due to TCR affinity or IL-2 signaling
alone (Fig. 4, D and E, top, and table S6). By
summation of these individual contributions to
themean and variance of the DD distribution, we
predicted the effect of a combined increase in TCR
affinity and IL-2 signaling on DD (Fig. 4E, bottom)
and successfully recreated the expansion kinetics
of OT-I/Il2ra+/+ CD8+ T cells during an HKx31-
N4 infection (Fig. 4F).
Manipulating T cell responses by costimulation
and cytokine signaling is an important emerging
therapeutic regimen (28, 29), and a quantitative
framework will facilitate the rational develop-
ment of optimal interventions. To support this
goal, we propose a quantitative paradigm where
no one signal is obligatory but rather combina-
tions of inputs add together to geometrically en-
hance outcomes (Fig. 1A). Thus, combinations of
different costimulatory and cytokine signals pro-
vide many alternative paths to generate T cell
responses of similar magnitude. This framework
reconciles long-standing discrepancies between
in vivo and in vitro results for IL-2 and costim-
ulatory signals and reveals a quantitative basis
for current switch-inspired two- and three-signal
models of activation. Further studies measuring
simultaneous differentiation changes to effector
and memory states associated with cell division
would complete the T cell calculating framework
and further enhance our ability to predict thera-
peutic strategies for immunomodulation.
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Fig. 4. In vivo summation of DD can predict Tcell
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T cells recovered from mLN, spleen, and lungs after
cotransfer of equal numbers of each into HKx31-N4–
infected recipients. Mean T SEM, n = 5 to 10 mice per
timepoint, pooled from two independent experiments;
two-way analysis of variance (ANOVA). (B and C)
CTV-labeled OT-I/Il2ra+/+ and OT-I/Il2ra–/– CD8+ T
cells were co-transferred to recipient mice at a 30:70
ratio 1 day before engraftment under the renal capsule
with islets expressing membrane-bound ovalbumin
under the rat insulin promoter. Mice were pulsed with
BrdU 1 hour before organ harvesting on day 6 after
engraftment, and the ratio of OT-I/Il2ra+/+:OT-I/Il2ra–/–
of (B) divided CD8+ Tcells and (C) the percentage
of divided CD8+ Tcells positive for BrdU+ within their
respective genotype populations was measured in
the renal (draining) lymph node (rLN) and graft.
Mean T SEM, n = 4 mice, representative of two inde-
pendent experiments; two-way ANOVA and one-tailed t
test, respectively. For all experiments, data points were
excluded from ratio and percentage calculations when
less than 100cellsweredetected.Dotted lines in (A)and
(B) represent the OT-I/Il2ra+/+:OT-I/Il2ra−/− transfer ratio. (D) The Cyton model
was fitted to OT-I/Il2ra+/+ and OT-I/Il2ra−/−CD8+ Tcell numbers from HKx31-Q4–
infectedmice and OT-I/Il2ra−/−CD8+ Tcells fromHKx31-N4–infectedmice pooled
from the mLN, spleen, and lungs after cotransfer of equal numbers of cells into
recipient mice, and (E) the division destiny distribution was determined (top) (19).
By summation of mean and variance of these DD distributions, the cumulative
effect of increasing TCR-antigen affinity and IL-2 signaling on the DD distribution
(i.e., theDDdistribution forOT-I/Il2ra+/+CD8+Tcells inHKx31-N4–infectedmice)
was predicted (bottom). (F) Using this mean and variance, the cell number over
timewas predicted forOT-I/Il2ra+/+CD8+Tcells inHKx31-N4–infectedmice (19).
Mean T SEM; n = 5 mice per time point, representative of two independent
experiments. ****P < 0.0001; ***P < 0.001; **P < 0.01; *P < 0.05.
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DNA REPAIR
Mechanism of DNA interstrand
cross-link processing by repair
nuclease FAN1
Renjing Wang,1 Nicole S. Persky,1 Barney Yoo,2 Ouathek Ouerfelli,2
Agata Smogorzewska,3 Stephen J. Elledge,4,5 Nikola P. Pavletich1*
DNA interstrand cross-links (ICLs) are highly toxic lesions associated with cancer and
degenerative diseases. ICLs can be repaired by the Fanconi anemia (FA) pathway and
through FA-independent processes involving the FAN1 nuclease. In this work, FAN1-DNA
crystal structures and biochemical data reveal that human FAN1 cleaves DNA successively
at every third nucleotide. In vitro, this exonuclease mechanism allows FAN1 to excise an ICL
from one strand through flanking incisions. DNA access requires a 5′-terminal phosphate
anchor at a nick or a 1- or 2-nucleotide flap and is augmented by a 3′ flap, suggesting that
FAN1 action is coupled to DNA synthesis or recombination. FAN1’s mechanism of ICL
excision is well suited for processing other localized DNA adducts as well.
D
NA interstrand cross-links (ICLs) covalent-
ly link together the two strands of the
double helix (1). ICLs can be repaired by
the Fanconi anemia (FA) pathway of pro-
teins mutated in the FA cancer predispo-
sition syndrome (2) and also by FA-independent
processes (1, 3, 4). The FA pathway is activated
when a replication fork stalls upon encounter-
ing an ICL, leading to unhooking of the ICL
through flanking incisions on one strand, trans-
lesion DNA synthesis across the unhooked ICL,
removal of the ICL remnants by additional in-
cisions, and homologous recombination (2, 5).
The FAN1 nuclease (6–9) is a candidate for me-
diating FA-independent repair (1, 3, 4). Although
FAN1 mutations result in defective ICL repair,
chromosomal instability, and hypersensitivity to
a wide range of ICL-inducing agents (6–13), they
do not cause FA (10–12). Instead, they cause a kid-
ney degeneration disorder knownas karyomegalic
interstitial nephritis (11). FAN1 cleaves branched
DNA structures with a preference for 5′-flap sub-
strates and also exhibits 5′- to 3′-exonuclease activ-
ity on a variety of double-stranded DNA (dsDNA)
and single-stranded DNA (ssDNA) substrates (6–9).
The functional implications of these broadly de-
fined activities, whether FAN1 processes ICLs di-
rectly and in which manner, and the structural
mechanism of ICL unhooking by nucleases are
unknown.
To address these questions, we first inves-
tigated FAN1’s DNA binding specificity for var-
ious lengths of 5′ flaps consisting of thymidine
nucleotides (see supplementary materials and
methods). We found that FAN1 exhibits spec-
ificity for a 5′ phosphate group at a flap of 1 to 2
nucleotides (nts) or at a nick, with dissociation
constants (Kd) of 10.3 nM for the 1-nt flap (5′pT1),
121 nM for 2 nts (5′pT2), and 182 nM for the nick
(pNi) (fig. S1A). The corresponding substrates
lacking the 5′ phosphate group fail to bind ap-
preciably until micromolar FAN1 concentrations
(fig. S1A). Similarly, increasing the flap length
beyond 2 nts reduces FAN1 affinity substantial-
ly (fig. S1A). We also tested the effect of adding a
3′ flap of eight thymidine nucleotides to the high-
affinity 5′pT1 (5′pT1/3′T8), 5′pT2 (5′pT2/3′T8), and
5′pNi (5′pNi /3′T8) and found that this increased
their FAN1 affinity by a factor of ~25 to ~180
(Kd values of 0.4, 1.4, and 1.0 nM, respectively)
(fig. S1B). By contrast, adding a 3′T8 flap to the
low-affinity 5′pT8 (5′pT8/3′T8) minimally en-
hanced its affinity, with the resulting 377 nM Kd
a factor of ~1000 weaker than that of 5′pT1/3′T8
(fig. S1B).
Based on these findings, we determined the
2.9 Å structure of a 5′pG1/3′T4 DNA bound to
humanFAN1 (residues 364 to 1017), N-terminally
truncated to remove the ubiquitin-binding UBZ
domain and subsequent unstructured segment,
as well as the structure of apo-FAN1 (fig. S2A and
table S1). FAN1 has a bilobal structure consisting
of a 223-residue N-terminal domain (NTD) and a
415-residue C-terminal domain (CTD) that con-
tains the PD-(D/E)XK nuclease motif (Fig. 1, A
and B). The DNA adopts a V-shaped structure,
with a kink at the nick. The prenick and postnick
duplexes have an overall B-form DNA (B-DNA)
conformation, with a 76° angle between them.
The prenick duplex and 3′ flap are bound by the
NTD, whereas the 5′ flap and postnick duplex are
bound by the CTD. There are no major confor-
mational changes between the apo- and DNA-
bound FAN1 structures (fig. S2B).
The NTD consists of a helical domain, a winged-
helix DNA binding domain, and the predicted SAP
domain (Fig. 1C). These form a continuous surface
that binds to a 9–base pair duplex segment lead-
ing to the 3′ flap and to a 2-nt segment of the flap
(Fig. 1A and fig. S3, A to D). The duplex contacts
involve only phosphodiester groups (fig. S3, A to
D), except for the flap-proximal base pair, which is
contacted at both its phosphodiester and base
groups (Fig. 2A). These base contacts block the
DNA from extending as a regularly stacked duplex,
analogous to the helix-breaking wedges observed
with other structure-specific nucleases (14, 15).
Only the first two nucleotides of the 3′T4 flap
are ordered. These extend away from the duplex
and are bound by FAN1 (Fig. 2A). The base and
ribose groups of the first nucleotide are contacted
by Tyr374, Val577, andArg581. The phosphate group
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Editor's Summary
 
 
 
, this issue p. 1123Science
linearly sum the various stimulatory inputs they receive to determine their ''division destiny.''
tracked antigen-specific T cell responses in mice infected with influenza virus. They found that T cells 
 stimulated mouse T cells in culture with different combinations of inputs and alsoet al.Marchingo 
But how do T cells integrate this information to determine the extent to which they divide? To find out,
costimulatory molecules, and cytokines at different times and anatomical locations during an infection. 
T cell activation is a dynamic process. T cells encounter multiple input signals such as antigens,
Stimulatory signals add up for T cells
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